Correction: An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Bioengineering and Biotechnology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2025.1642526/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849431061030764544 |
|---|---|
| author | Youngshim Choi Yinyan Ma Samson Tom Alla Danilkovitch Liqing Yu |
| author_facet | Youngshim Choi Yinyan Ma Samson Tom Alla Danilkovitch Liqing Yu |
| author_sort | Youngshim Choi |
| collection | DOAJ |
| format | Article |
| id | doaj-art-bcdc03203bdb47868b85d70735da066e |
| institution | Kabale University |
| issn | 2296-4185 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Bioengineering and Biotechnology |
| spelling | doaj-art-bcdc03203bdb47868b85d70735da066e2025-08-20T03:27:46ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852025-06-011310.3389/fbioe.2025.16425261642526Correction: An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver diseaseYoungshim Choi0Yinyan Ma1Samson Tom2Alla Danilkovitch3Liqing Yu4Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United StatesDivision of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United StatesBritecyte, Inc., Fredrick, MD, United StatesBritecyte, Inc., Fredrick, MD, United StatesDivision of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United Stateshttps://www.frontiersin.org/articles/10.3389/fbioe.2025.1642526/fulladipose tissueadipose stem cellstissue engineeringMASLDfibrosisinflammation |
| spellingShingle | Youngshim Choi Yinyan Ma Samson Tom Alla Danilkovitch Liqing Yu Correction: An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease Frontiers in Bioengineering and Biotechnology adipose tissue adipose stem cells tissue engineering MASLD fibrosis inflammation |
| title | Correction: An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease |
| title_full | Correction: An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease |
| title_fullStr | Correction: An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease |
| title_full_unstemmed | Correction: An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease |
| title_short | Correction: An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease |
| title_sort | correction an engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction associated steatotic liver disease |
| topic | adipose tissue adipose stem cells tissue engineering MASLD fibrosis inflammation |
| url | https://www.frontiersin.org/articles/10.3389/fbioe.2025.1642526/full |
| work_keys_str_mv | AT youngshimchoi correctionanengineeredadiposeformulationdecreaseshepaticinflammationandfibrosisinarodentmodelofmetabolicdysfunctionassociatedsteatoticliverdisease AT yinyanma correctionanengineeredadiposeformulationdecreaseshepaticinflammationandfibrosisinarodentmodelofmetabolicdysfunctionassociatedsteatoticliverdisease AT samsontom correctionanengineeredadiposeformulationdecreaseshepaticinflammationandfibrosisinarodentmodelofmetabolicdysfunctionassociatedsteatoticliverdisease AT alladanilkovitch correctionanengineeredadiposeformulationdecreaseshepaticinflammationandfibrosisinarodentmodelofmetabolicdysfunctionassociatedsteatoticliverdisease AT liqingyu correctionanengineeredadiposeformulationdecreaseshepaticinflammationandfibrosisinarodentmodelofmetabolicdysfunctionassociatedsteatoticliverdisease |